Abstract:OBJECTIVES: To evaluate the diagnostic yield of prenatal whole exome sequencing (WES) for monogenic disorders in fetuses with structural malformations and normal results on cytogenetic testing, and to describe information on pathogenic variants that is provided by WES.METHODS: Karyotyping, chromosomal microarray analysis (CMA) and WES were performed sequentially on stored samples from a cohort of 3949 pregnancies with fetal structural abnormalities detected on ultrasound and/or magnetic resonance imaging, referred between January 2011 and December 2015. Diagnostic rates of the three techniques were investigated overall, for phenotypic subgroups and for proband-only vs fetus-mother-father samples. Information on pathogenic variants was identified by WES.RESULTS: Overall, 18.2% (720/3949) of fetuses had an abnormal karyotype. Pathogenic copy number variants were detected on CMA in 8.2% (138/1680) of fetuses that had a normal karyotype result. WES performed on a subgroup of 196 fetuses with normal CMA and karyotype results revealed the putative genetic variants responsible for the abnormal phenotypes in 47 cases (24%). The molecular diagnosis rates for fetus-mother-father and proband-only samples were 26.5% (13/49) and 23.1% (34/147), respectively. Variants of uncertain significance were detected in 12.8% (25/196) of fetuses, of which 22 were identified in the fetal proband-only group (15%; 22/147) and three in the fetus-mother-father group (6.1%; 3/49). The incidental finding rate was 6.1% (12/196).CONCLUSIONS: WES is a promising method for the identification of genetic variants that cause structural abnormalities in fetuses with normal results on karyotyping and CMA. This enhanced diagnostic yield has the potential to improve the clinical management of pregnancies and to inform better the reproductive decisions of affected families. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

EP06.12: Prospective reanalysis of unsolved prenatal exome sequencing: diagnostic yield and contribution of postnatal/post‐mortem findings

OP10.09: Prenatal exome sequencing: a powerful tool to improve description of prenatal features related to genetic disorders

EP18.17: Whole exome sequencing in prenatal diagnosis: anomaly of low diagnostic yield and incidental findings management

Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder

Discovery of pathogenic variants in EFEMP2 and RAG1 and undetectable fetal phenotype: A challenge of prenatal exome sequencing

EP06.75: Analysis of prenatal ultrasound findings in neonates diagnosed with genetic disorders through next‐generation sequencing

Promises, pitfalls and practicalities of prenatal whole exome sequencing

EP18.27: Whole genome sequencing, potential for a primary diagnostic test in the management of prenatally detected congenital malformations

Exome Sequencing Analysis on Products of Conception: a Cohort Study to Evaluate Clinical Utility and Genetic Etiology for Pregnancy Loss

Potentially Missed Diagnoses in Prenatal Versus Postnatal Exome Sequencing in the Lack of Informative Phenotype: Lessons Learned From a Postnatal Cohort

The High Diagnostic Yield of Prenatal Exome Sequencing Followed by 3400 Gene Panel Analysis in 629 Ongoing Pregnancies With Ultrasound Anomalies

Molecular diagnostic yield of exome sequencing in a Chinese cohort of 512 fetuses with anomalies

Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta‐analysis

EP18.25: Exome sequencing reveals patterns in recurrent isolated fetal anomalies: insights from three case reports

High‐throughput sequencing in prenatal care: how to combine diagnostic performance and best practice?

Prenatal exome sequencing for morphologically normal fetus: Should we be doing it?

EP01.04: Improving early gene detection using a new bioinformatics tool specific to prenatal phenotyping: a case study on CHARGE syndrome

EP03.02: Long‐term developmental outcomes of children with a prenatal diagnosis of a variant of uncertain significance: the PrenatAL Microarray (PALM) study

EP06.19: Prenatal diagnosis of Bardet‐Biedl Syndrome

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

EP06.09: Expanding prenatal ultrasonographic features in fetal akinesia deformation sequence 3 confirmed by post‐mortem examination